References

Guillain-Barré syndrome.

10.1016/s0140-6736(21)00517-1 · 2021 · External reference

Guillain-Barré syndrome.

10.1016/s0140-6736(05)67665-9 · 2005 · External reference

Ganglioside molecular mimicry and its pathological roles in Guil-lain-Barré syndrome and related diseases.

10.1128/iai.00967-06 · 2006 · External reference

COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.

10.1002/iid3.875 · 2023 · External reference

Guillain-Barré syndrome.

10.1016/s0140-6736(16)00339-1 · 2016 · External reference

Herpes Simplex Virus 1 Infection of Neuronal and Non-Neuronal Cells Elicits Specific Innate Immune Responses and Immune Evasion Mechanisms.

10.3389/fimmu.2021.644664 · 2021 · External reference

A Rare Association Between Herpes Simplex Virus Type 1 and Miller-Fisher Syndrome.

2023 · External reference

Guillain-Barré syndrome: expanding the con-cept of molecular mimicry.

10.1016/j.it.2022.02.003 · 2022 · External reference

A rare association of Guillain-Barré syndrome/Miller-Fisher syndrome overlap syndrome and Herpes Simplex Virus Type 1 infection: trigger or exacerbating factor?

10.1177/17562864241297086 · 2024 · External reference

Antigenic cross-reactions among herpes sim-plex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus.

10.1128/jvi.61.4.1125-1135.1987 · 1987 · External reference

A rare association of Guillain-Barré syndrome/Miller-Fisher syndrome overlap syndrome and Herpes Simplex Virus Type 1 infection: trigger or exacerbating factor?

10.1177/17562864241297086 · 2024 · External reference

Exploring Treatments for a Rare Guillain-Barré Variant: A Case Report of Miller-Fisher Syndrome.

2024 · External reference

Advances and Perspectives in the Management of Varicella-Zoster Virus Infections.

10.3390/molecules26041132 · 2021 · External reference

Guillain-Barré syndrome following varicella-zoster virus infection: a case report and systematic review.

10.1097/ms9.0000000000001370 · 2023 · External reference

Varicella-zoster virus: molecular controls of cell fu-sion-dependent pathogenesis.

10.1042/bst20190511 · 2020 · External reference

Cytomegalovirus: epidemiology and infection control.

10.1016/0196-6553(87)90164-7 · 1987 · External reference

CMV-associated axonal sensory-motor Guillain-Barré syndrome in a child: Case report and review of the literature.

10.1016/j.ejpn.2015.11.004 · 2016 · External reference

Guillain–Barré syndrome, transverse myelitis and infectious diseases.

10.1038/cmi.2017.142 · 2018 · External reference

Antiganglioside antibod-ies in Guillain-Barré syndrome after a recent cytomegalovirus infection.

10.1136/jnnp.66.3.376 · 1999 · External reference

Guillain-Barré Syn-drome in a Teenage Girl: A Severe Case With Anti-GM2 Antibodies Associated With Acute CMV Infection and Literature Review.

10.1177/0009922819898186 · 2020 · External reference

Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study.

10.1093/cid/cir074 · 2011 · External reference

Mild form of Guillain-Barré syndrome in a patient with primary Epstein-Barr virus infection.

10.3904/kjim.2015.033 · 2016 · External reference

Guil-lain-Barré syndrome in the course of EBV infection after kidney transplantation--a case report.

10.12659/aot.883468 · 2012 · External reference

Role of infection in Guillain-Barré syndrome: laboratory confirma-tion of herpesviruses in 41 cases.

10.1002/ana.410090709 · 1981 · External reference

Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.

10.1007/s12031-020-01767-6 · 2021 · External reference

Guillain Barré Syn-drome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series.

10.1016/j.jns.2020.117263 · 2021 · External reference

Neurological manifesta-tions associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.

10.1016/j.neurol.2020.10.001 · 2021 · External reference

Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection.

10.1016/j.nbd.2022.105715 · 2022 · External reference

Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review.

10.1017/cjn.2021.102 · 2022 · External reference

Is Guillain-Barrè syn-drome triggered by SARS-CoV-2? Case report and literature review.

10.1007/s10072-020-04553-9 · 2021 · External reference

Guillain-Barré syn-drome in the COVID-19 era: just an occasional cluster?

10.1007/s00415-020-09911-3 · 2021 · External reference

Clin-ical Features of Guillain-Barré Syndrome With vs Without Zika Virus Infection, Puerto Rico, 2016.

10.1001/jamaneurol.2018.1058 · 2018 · External reference

Neurologic Complications Associated With the Zika Virus in Brazilian Adults.

10.1001/jamaneurol.2017.1703 · 2017 · External reference

Guil-lain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

10.1016/s0140-6736(16)00562-6 · 2016 · External reference

Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

10.1128/microbiolspec.gpp3-0045-2018 · 2019 · External reference

Physiology of gangliosides and the role of antiganglioside antibodies in human diseases.

10.1038/s41423-020-0388-9 · 2020 · External reference

Brain-reactive antibodies and dis-ease.

10.1146/annurev-immunol-020711-075041 · 2013 · External reference

Guillain-Barré syndrome: History, pathogenesis, treatment, and future direc-tions.

10.1111/ene.16346 · 2024 · External reference

Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwe-gian population-based cohort study.

10.1007/s10654-015-0047-0 · 2016 · External reference

Incidence of Guillain-Barré Syndrome Is Not Associated with Influenza Vaccination in the Elderly.

10.3390/vaccines8030431 · 2020 · External reference

Evolution and Impact of Hepatitis A Epidemiology in Europe-Systematic Literature Review of the Last 20 Years.

10.1111/jvh.14030 · 2025 · External reference

From hepatitis A to E: A critical review of viral hepatitis.

10.3748/wjg.v27.i16.1691 · 2021 · External reference

HAV-induced acalculous cholecystitis: A case report and literature review.

10.1002/ccr3.7254 · 2023 · External reference

Factors Associated With Hepatitis A Mortality During Person-to-Person Outbreaks: A Matched Case-Control Study-United States, 2016-2019.

10.1002/hep.31645 · 2021 · External reference

The immune response during acute HIV-1 infection: clues for vaccine development.

10.1038/nri2674 · 2010 · External reference

An unusual presentation of hepatitis A virus infection: Guillain-Barré syndrome.

10.1258/004947506778604706 · 2006 · External reference

Trauma-Related Guillain-Barré Syndrome: Sys-tematic Review of an Emerging Concept.

10.3389/fneur.2020.588290 · 2020 · External reference

Guillain-Barré Syndrome and Variants.

10.1016/j.ncl.2013.01.005 · 2013 · External reference

Is there a link between Hepatitis A virus and Guillain-Barré syndrome? A systematic review of case reports.

10.1016/j.ensci.2025.100551 · 2025 · External reference

Diagnosis and management of Guillain-Barré syndrome in ten steps.

10.1038/s41582-019-0250-9 · 2019 · External reference

Unilateral facial palsy in Guillain-Barre syndrome (GBS): a rare occurrence.

10.1136/bcr-2012-007077 · 2012 · External reference

Guillain-Barré syndrome following fulminant viral hepatitis A.

10.2169/internalmedicine.33.799 · 1994 · External reference

Case report: Hepatitis A preced-ing Guillain-Barré syndrome.

10.1002/jmv.20656 · 2006 · External reference

The Guillain-Barré syndrome: a true case of molecular mimicry.

10.1016/j.it.2003.12.004 · 2004 · External reference

Vertical Transmission of Hepatitis B Virus-An Update.

10.3390/microorganisms11051140 · 2023 · External reference

Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies.

10.3748/wjg.v30.i10.1295 · 2024 · External reference

Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.

10.1053/j.gastro.2017.02.009 · 2017 · External reference

Explore genetic susceptibility associ-ation between viral infections and Guillain-Barré syndrome risk using two-sample Mendelian ran-domization.

10.1186/s12967-024-05704-8 · 2024 · External reference

A rare case of acute hepatitis B virus infec-tion causing guillain-barré syndrome.

2013 · External reference

Vaccines and the risk of Guillain-Barré syndrome.

10.1007/s10654-019-00596-1 · 2020 · External reference

Demyelination in multiple sclerosis.

10.1016/b978-0-444-52001-2.00004-2 · 2014 · External reference

Severe Guillain-Barré syndrome associated with chronic hepatitis B: A case report and literature review.

10.1097/md.0000000000027989 · 2021 · External reference

The immunology of inflammatory demyelinating dis-ease. McAlpine’s.

2006 · External reference

Guillain–Barre syndrome: small-volume plasmapheresis versus intravenous immunoglobulin - 3rd level hospital experience.

10.1186/s41983-024-00820-0 · 2024 · External reference

Virus-Lipid Interplay: Pathogene-sis and Clinical Impact.

10.3390/biomedicines11020271 · 2023 · External reference

Reactivation of Chronic Hepatitis C as a Potential Trigger for Guillain-Barré Syndrome.

2019 · External reference

TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor au-toantibody responses.

10.1016/j.jhep.2019.06.029 · 2019 · External reference

NATURAL HISTORY OF HEPATITIS C.

10.1016/j.gtc.2015.07.003 · 2015 · External reference

Guil-lain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

10.1038/nrneurol.2014.121 · 2014 · External reference

Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.

10.1053/j.gastro.2018.08.060 · 2019 · External reference

Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection.

10.1038/s41598-020-58768-z · 2020 · External reference

Guillain-Barré syndrome associated with preceding hepatitis E virus infection.

10.1212/wnl.0000000000000111 · 2014 · External reference

Guillain-Barre syndrome caused by hepatitis E infec-tion: case report and literature review.

10.1186/s12879-018-2959-2 · 2018 · External reference

Guillain-Barré syndrome.

10.1056/nejmra1114525 · 2012 · External reference

GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.

10.1212/01.wnl.0000335160.72184.7d · 2008 · External reference

Ganglioside mimicry as a cause of Guillain-Barré syndrome.

10.2174/187152706777950765 · 2006 · External reference

HIV seroconver-sion manifesting as Guillian-Barre syndrome.

10.3760/cma.j.issn.0366-6999.20131338 · 2014 · External reference

Acute Guillain-Barré syndrome during the chronic phase of HIV infection and dramatic improvement under highly active an-tiretroviral therapy.

10.1097/00002030-200207260-00017 · 2002 · External reference

Functional recovery of untreated human immu-nodeficiency virus-associated Guillain-Barré syndrome: a case report.

10.1016/j.rehab.2011.09.009 · 2011 · External reference

Profile of neurological admis-sions at the University of Nigeria Teaching Hospital Enugu.

10.4314/njm.v19i4.61967 · 2010 · External reference

Effect of human immunodeficiency virus on intensive care unit outcome of patients with Guillain-Barré syndrome.

10.1097/01.ccm.0000069516.81522.f4 · 2003 · External reference

Neurologic signs and symptoms frequently manifest in acute HIV infection.

10.1212/wnl.0000000000002837 · 2016 · External reference

Refractory HIV-Associated Guillain-Barré Syndrome Responsive to Antiretroviral Therapy: A Case Report.

2024 · External reference

Guillain-Barré syndrome spectrum as manifestation of HIV-related immune reconstitution inflammatory syndrome: case report and literature review.

10.1016/j.bjid.2022.102368 · 2022 · External reference

Guillain-Barré Syndrome with Fatal Outcome during HIV-1-Seroconversion: A Case Report.

2011 · External reference

Poly-neuropathy induced by HIV disease and antiretroviral therapy.

10.1016/j.clinph.2012.05.022 · 2013 · External reference

Antibody neutralization and escape by HIV-1.

10.1038/nature01470 · 2003 · External reference

HIV Infection, Antiretroviral Drugs, and the Vascular Endothelium.

10.3390/cells13080672 · 2024 · External reference

Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins.

10.1016/j.bbrc.2005.05.198 · 2005 · External reference

Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection.

10.1016/b978-0-444-64012-3.00006-x · 2019 · External reference

Cardiovascular Events Recurrence and Coronary Artery Disease in HIV Patients: The Price We Have to Pay for the Chronicization of the Disease.

2020 · External reference

Primary lung cancer diagnoses in people living with HIV in a large clinical centre in Montreal, Canada over 3 decades.

10.1080/09540121.2020.1758614 · 2020 · External reference

HIV positive patient with GBS-like syn-drome.

10.1099/jmmcr.0.005107 · 2017 · External reference

Guil-lain-Barre syndrome presenting with sensory disturbance following a herpes virus infection: a case report.

10.1186/1752-1947-5-563 · 2011 · External reference

Guillain-Barre syn-drome of acute motor axonal neuropathy (AMAN) type associated with herpes zoster: a case report.

10.1186/s12883-024-03607-1 · 2024 · External reference